Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000442643 | SCV000513480 | benign | not specified | 2017-10-24 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001082170 | SCV000652153 | benign | Lipoic acid synthetase deficiency | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000712219 | SCV000842657 | likely benign | not provided | 2017-09-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003168627 | SCV003889152 | likely benign | Inborn genetic diseases | 2023-02-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV000712219 | SCV005257304 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003970117 | SCV004781474 | benign | LIAS-related disorder | 2019-08-28 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |